Champions Oncolog (CSBR)

$7.65 -0.52 (-6.36%)
Market Cap 119.05M
Revenue (ttm) 50.16M
Net Income (ttm) -7.28M
EPS (ttm) N/A
PE Ratio 19.57
Forward PE N/A
Profit Margin -14.51%
Debt to Equity Ratio 0.00
Volume 26,333
Avg Vol 46,180
Day's Range N/A - N/A
Shares Out 13.83M
Stochastic %K 6%
Beta 0.46
Analysts Strong Sell
Price Target $12.00

Latest News on CSBR

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Mar 11, 2025, 8:07 PM EDT - 23 days ago

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Mar 11, 2025, 3:55 PM EDT - 23 days ago

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Mar 6, 2025, 4:00 PM EST - 4 weeks ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Feb 18, 2025, 9:00 AM EST - 6 weeks ago

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Jan 8, 2025, 8:00 AM EST - 3 months ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Dec 27, 2024, 9:00 AM EST - 3 months ago

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Dec 11, 2024, 6:02 PM EST - 4 months ago

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Dec 11, 2024, 4:00 PM EST - 4 months ago

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Dec 5, 2024, 4:30 PM EST - 4 months ago

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Champions Oncology Announces Agreement with Weill Cornell Medicine

Oct 16, 2024, 10:55 AM EDT - 6 months ago

Champions Oncology Announces Agreement with Weill Cornell Medicine

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Sep 11, 2024, 8:52 PM EDT - 7 months ago

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Sep 11, 2024, 4:00 PM EDT - 7 months ago

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Sep 9, 2024, 4:00 PM EDT - 7 months ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Jul 18, 2024, 6:11 PM EDT - 9 months ago

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 18, 2024, 4:00 PM EDT - 9 months ago

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Jul 11, 2024, 4:05 PM EDT - 9 months ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Jun 4, 2024, 9:00 AM EDT - 10 months ago

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Mar 12, 2024, 7:21 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Mar 12, 2024, 4:30 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Mar 7, 2024, 9:00 AM EST - 1 year ago

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Mar 6, 2024, 4:35 PM EST - 1 year ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Dec 12, 2023, 5:54 PM EST - 1 year ago

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Dec 12, 2023, 4:00 PM EST - 1 year ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Dec 4, 2023, 4:30 PM EST - 1 year ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Nov 2, 2023, 8:30 AM EDT - 1 year ago

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Champions Oncology Announces the Addition of Brady Davis as President

Oct 17, 2023, 8:30 AM EDT - 1 year ago

Champions Oncology Announces the Addition of Brady Davis as President

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Sep 15, 2023, 1:34 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Sep 13, 2023, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Sep 11, 2023, 4:00 PM EDT - 1 year ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Aug 22, 2023, 8:30 AM EDT - 1 year ago

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Aug 1, 2023, 8:45 AM EDT - 1 year ago

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Jul 24, 2023, 6:34 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Jul 24, 2023, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Jul 20, 2023, 4:00 PM EDT - 1 year ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Apr 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Champions Oncology Announces $5M Stock Repurchase Program

Apr 5, 2023, 9:50 AM EDT - 2 years ago

Champions Oncology Announces $5M Stock Repurchase Program

Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript

Mar 17, 2023, 3:52 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.8 Million

Mar 15, 2023, 3:50 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.8 Million

Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

Mar 13, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023

Champions Oncology Trades At A Sufficient Discount To R&D Capacity

Jan 29, 2023, 12:37 AM EST - 2 years ago

Champions Oncology Trades At A Sufficient Discount To R&D Capacity

Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript

Dec 13, 2022, 8:54 PM EST - 2 years ago

Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

Dec 13, 2022, 4:00 PM EST - 2 years ago

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

Dec 9, 2022, 4:30 PM EST - 2 years ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

Champions Oncology, Inc. (CSBR) Q1 2023 Earnings Call Transcript

Sep 9, 2022, 4:41 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q1 2023 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

Sep 8, 2022, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022

Sep 6, 2022, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022

Champions Oncology Reports Quarterly Revenue of $12.9 Million

Jul 21, 2022, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.9 Million

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

Jul 14, 2022, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

May 31, 2022, 8:30 AM EDT - 3 years ago

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo

May 3, 2022, 8:30 AM EDT - 3 years ago

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo